Cargando…
More intensive hepatitis C virus care models promote adherence among people who inject drugs with active drug use: The PREVAIL study
Autores principales: | Heo, Moonseong, Pericot‐Valverde, Irene, Niu, Jiajing, Norton, Brianna L., Akiyama, Matthew J., Nahvi, Shadi, Arnsten, Julia H., Litwin, Alain H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851956/ https://www.ncbi.nlm.nih.gov/pubmed/36197920 http://dx.doi.org/10.1111/jvh.13756 |
Ejemplares similares
-
Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial
por: Pericot-Valverde, Irene, et al.
Publicado: (2020) -
Declines in Depressive Symptoms Among People who Inject Drugs Treated With Direct-Acting Antivirals While on Opioid Agonist Therapy
por: Pericot-Valverde, Irene, et al.
Publicado: (2020) -
Low Adherence Achieves High HCV Cure Rates Among People Who Inject Drugs Treated With Direct-Acting Antiviral Agents
por: Norton, Brianna L, et al.
Publicado: (2020) -
Changes in alcohol use during hepatitis C treatment in persons who inject drugs
por: Martin, Madhuri, et al.
Publicado: (2022) -
Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO Study
por: Pericot-Valverde, Irene, et al.
Publicado: (2023)